AKANNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
AKANDA CORP.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 9, 2026
$1.12−0.08 (-6.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Akanda statistics
Financials through Jun 30, 2025, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Akanda | Industry median |
|---|---|---|
| Market Cap | $2.22M | $164.85M |
| Enterprise Value | -$123.68K | $87.06M |
| PS Ratio | 2.66 | 3.60 |
Enterprise value
| Measure | Akanda | Industry median |
|---|---|---|
| EV / Sales | -0.15 | 2.43 |
Income (trailing twelve months)
| Measure | Akanda | Industry median |
|---|---|---|
| Revenue | $836.66K | $57.94M |
| Gross Profit | $208.38K | $90.47M |
| Operating Income | -$4.38M | -$21.44M |
| EBITDA | -$4.24M | -$16.91M |
| EPS (Diluted) | -$3.93 | -$0.83 |
Margins
| Measure | Akanda | Industry median |
|---|---|---|
| Gross Margin | 24.9% | 52.3% |
| Operating Margin | -523.8% | -44.5% |
| EBITDA Margin | -506.9% | -31.3% |
| FCF Margin | -726.5% | -8.85% |
Returns
| Measure | Akanda | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -130.0% | -37.8% |
Growth
| Measure | Akanda | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 97.5% | 6.01% |
| Revenue Growth (3Y CAGR) | 172.3% | 2.25% |
Balance sheet
| Measure | Akanda | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.53M | $62.42M |
| Total Debt | $184.29K | $120.13M |
| Net Cash (Debt) | $2.35M | $15.68M |
| Net Cash Per Share | $1.18 | $0.66 |
| Working Capital | $724.28K | $75.77M |
Financial position
| Measure | Akanda | Industry median |
|---|---|---|
| Current Ratio | 1.25 | 3.30 |
| Quick Ratio | 0.89 | 2.39 |
| Interest Coverage | -43.78 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Akanda | Industry median |
|---|---|---|
| Operating Cash Flow | -$3.98M | -$12.35M |
| Capital Expenditures | -$2.10M | -$1.06M |
| Free Cash Flow | -$6.08M | -$20.28M |
| FCF Per Share | -$3.06 | -$0.42 |
Efficiency
| Measure | Akanda | Industry median |
|---|---|---|
| Asset Turnover | 0.13 | 0.38 |
| Revenue Per Employee | $418.33K | $398.96K |
| Employee Count | 2 | 74 |
Dividends and yields
| Measure | Akanda | Industry median |
|---|---|---|
| FCF Yield | -273.6% | -9.07% |
| Buyback Yield | -484.1% | -0.73% |
| Shareholder Yield | -484.1% | 0.00% |
Shares
| Measure | Akanda | Industry median |
|---|---|---|
| Shares Outstanding | 1,983,550 | 58,179,650 |
| Shares Change (YoY) | 1750.3% | 11.1% |
| Float | 1,967,860 | 49,173,100 |
| Shares Held by Insiders | 0.79% | 11.6% |
| Shares Held by Institutions | 0.04% | 59.4% |
Scores
| Measure | Akanda | Industry median |
|---|---|---|
| Altman Z-Score | -14.72 | -0.24 |
Calculated by StockData from Akanda's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.